bioRxiv Science⌕ Search

Biology subjects

D'Santos, C.

Publications and source records attributed to D'Santos, C..

6 recordsLinked to original sources

Temporal phosphoproteomic programmes set a redox-gated rheostat on neutrophil phagocytosis

Neutrophils are essential frontline immune cells in the defence against bacterial pathogens such as Staphylococcus aureus, but their killing machinery also causes host tissue damage. How neutrophils regulate these processes remains incompletely understood. Here, we profile the proteome and phosphoproteome of human neutrophils across a two-hour exposure to S. aureus, alongside five simultaneous functional readouts, before investigating how an initial encounter modulates the response to a second. The phosphoproteomic response resolves into qualitatively distinct early and late windows: the early landscape drives particle uptake, while by the late window this machinery is been deactivated, with a broadly supressed kinome, and cells geared towards inflammatory output. Correlating protein phosphorylation and functional kinetics - an approach we term KINETIC - implicates putative mediators of key neutrophil antimicrobial functions. A genome-wide CRISPR knockout screen in neutrophil-like PLB-985 cells, sorted on phagocytic load, recovers canonical engulfment machinery among the strongest facilitators of phagocytosis, additionally identifying the lysosomal Ragulator-mTORC1 nutrient sensing pathway and HOPS complex corresponding to the KINETIC-identified pathways. Conversely, the NRF2 repressor KEAP1 is revealed as the strongest phagocytic brake, positioning oxidative burden as a regulator of phagocytic appetite. Neutrophils in the late window exhibit impaired phagocytosis and phagosomal acidification on S.aureus re-challenge. Underlying these functional deficits, cells in the late window are refractory across multiomic layers: a second S. aureus meal alters no phosphoprotein, protein, or transcript, whereas the chemoattractants PAF and fMLP evoke a largely consistent phosphoproteomic programme, delineating the phenotype as receptor-specific rather than a global loss of signalling capacity. Consistent with de-repressing the antioxidant response via genetic loss of KEAP1 increasing phagocytosis, reducing ROS production via inhibition of the NADPH oxidase results in a partial rescue of phagocytosis of the re-exposed S. aureus. Together, these findings describe a ROS-gated phagocytic rheostat, enabling neutrophils to meter their phagocytic appetite according to their exposure history, likely limiting uptake of pathogens they lack the capacity to effectively digest. Inappropriate activation of this rheostat under conditions of physiological stress or severe illness may underpin the defects in phagocytosis identified in such patients.

immunology↗

Dynamic TET1 repression coordinates activation of macroH2A.2-poised bivalent genes during neuroectoderm differentiation

Cell state transitions involve changes in gene expression programs in conjunction with epigenetic regulation occurring in chromatin. Bivalent chromatin, marked by overlapping active H3K4me3 and repressive H3K27me3, poises key developmental genes during pluripotency for cell type-specific activation during differentiation. However, the molecular mechanisms that activate bivalent genes during lineage commitment remain poorly understood. Here, we elucidate how the cytosine dioxygenase TET1 promotes neuroectoderm differentiation through dynamic chromatin binding and a non-catalytic repressor function. Through a hypothesis-free screen for TET1 chromatin complex partners, we find that TET1 physically interacts with macroH2A.2 and H2A.X on chromatin. Integrated multi-omic analyses reveal that the non-catalytic repressor function of TET1 and a novel activating function of the H2A variant macroH2A.2 together promote a poised transcriptional state within bivalent chromatin during pluripotency. Upon pluripotency exit, TET1 disengages from macroH2A.2-marked early neuroectoderm genes to permit their activation, while remaining bound as a repressor at mesoendoderm and late neural genes to prevent alternative cell state transitions. Furthermore, TET1 retention at accessible primed enhancers supports neural program activation. Together, our findings reveal a noncanonical functional interplay within bivalent chromatin between TET1 and macroH2A.2 that maintains a poised state during pluripotency and predicts selective gene activation during neuroectoderm specification.

developmental biology↗

IL-1-activated cancer-associated fibroblasts promote STAT1-driven transcriptional reprogramming of pancreatic tumour cells

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, with limited treatment options and poor survival rates. It is characterised by strong driver mutations, epigenetic reprogramming, and a dense tumour microenvironment (TME). A defining feature of the PDAC TME is its fibrotic stroma, which is largely composed of cancer-associated fibroblasts (CAFs). Distinct CAF populations have been implicated in PDAC progression, but the mechanisms that govern their crosstalk with the cancer cells are poorly understood. We generated genetically engineered pancreatic stellate cells (PSCs) modelling interleukin-1 (IL-1)-dependent inflammatory CAFs (iCAFs) and transforming growth factor-{beta} (TGF-{beta})-dependent myofibroblastic CAFs (myCAFs) to investigate how distinct stromal populations shape the epigenetic landscape of pancreatic ductal adenocarcinoma (PDAC). We found that iCAFs, but not myCAFs, promoted gemcitabine resistance in epithelial tumour cells and identified STAT1 as a critical mediator of iCAF-tumour cell crosstalk. Mechanistically, STAT1 drove the induction of interferon (IFN)-responsive genes, while blockade of IFN-{beta} attenuated iCAF-mediated transcriptional reprogramming. Genetic ablation of STAT1 in tumour cells abolished iCAF-induced chemoresistance and associated transcriptional changes. In an orthotopic in vivo model, STAT1 knockout significantly prolonged survival following gemcitabine treatment, supporting a central role for STAT1 signalling in stromal-driven therapy resistance. We provide a comprehensive analysis on how IL-1-dependent iCAFs contribute to epigenetic reprogramming in PDAC and uncover a previously undescribed role for STAT1 in stromal-epithelial interactions. These findings reveal distinct, non-overlapping mechanisms by which CAF subtypes modulate tumour behaviour and identify STAT1 as a therapeutic vulnerability that can be exploited to sensitise PDAC to standard chemotherapy. Significance statementThis study establishes that the epigenetic landscape of PDAC is differentially shaped by iCAF- and myCAF-like PSCs and defines STAT1 as a mediator of iCAF-induced chemoresistance and transcriptional reprogramming. We demonstrate that genetic ablation of STAT1 sensitises tumours to gemcitabine in vivo, extending survival and positioning STAT1 as an actionable target to overcome stromal-mediated therapy resistance in PDAC.

cancer biology↗

Childhood brain tumours instruct cranial haematopoiesis and immunotolerance

Recent research has revealed a remarkable role for immunosurveillance in healthy and diseased brains, dispelling the notion that this organ is a passive immune-privileged site1-3. Better understanding of how this immunosurveillance operates could improve the treatment of neurological diseases. Here, using a novel genetically engineered mouse model of ZFTA-RELA ependymoma4-a childhood brain tumour-we characterised an immune circuit between the tumour and antigen presenting, haematopoietic stem/progenitor cells (HSPCs) in the skull bone marrow. The presentation of antigens in the cerebrospinal fluid (CSF) by HSPCs to CD4+ T cells, biased HSPC lineages toward myelopoiesis and polarised CD4+ T-cells to regulatory T cells (T- regs), culminating in tumour immunotolerance. Remarkably, a single infusion of antibodies directed against cytokines enriched in the CSF of mice bearing ZFTA-RELA ependymomas, choroid plexus carcinomas or Group-3 medulloblastoma-all aggressive childhood brain tumours-disrupted this process and caused profound tumour regression. These data unmask a mechanism by which skull bone marrow-derived HSPCs and CD4+ T cells cooperate to promote the immunotolerance of childhood brain tumours. Antibodies that disrupt this immunosurveillance could prove an effective therapy for these cancers that are less toxic than current treatments.

immunology↗

Complement C5a impairs phagosomal maturation in the neutrophil through phosphoproteomic remodelling.

Critical illness is accompanied by the release of large amounts of the anaphylotoxin, C5a. C5a suppresses antimicrobial functions of neutrophils which is associated with adverse outcomes. The signalling pathways that mediate C5a-induced neutrophil dysfunction are incompletely understood. Healthy donor neutrophils exposed to purified C5a demonstrated a prolonged defect (7 hours) in phagocytosis of Staphylococcus aureus. Phosphoproteomic profiling of 2712 phosphoproteins identified persistent C5a signalling and selective impairment of phagosomal protein phosphorylation on exposure to S. aureus. Notable proteins included early endosomal marker ZFYVE16 and V-ATPase proton channel component ATPV1G1. A novel assay of phagosomal acidification demonstrated C5a-induced impairment of phagosomal acidification which was recapitulated in neutrophils from critically ill patients. Examination of the C5a-impaired protein phosphorylation indicated a role for the phosphatidylinositol 3-kinase VPS34 in phagosomal maturation. Inhibition of VPS34 impaired neutrophil phagosomal acidification and killing of S. aureus. This study provides a phosphoproteomic assessment of human neutrophil signalling in response to S. aureus and its disruption by C5a, identifying a defect in phagosomal maturation and new mechanisms of immune failure in critical illness.

immunology↗

Copy number aberrations drive kinase re-wiring leading to genetic vulnerabilities in cancer

Somatic DNA copy number variations (CNVs) are prevalent in cancer and can drive cancer progression albeit with often uncharacterized roles in altering cell signaling states. Here, we integrated genomic and proteomic data for 5598 tumor samples to identify CNVs leading to aberrant signal transduction. The resulting associations recapitulated known kinase-substrate relationships and further network analysis prioritized likely driver genes. A total of 44 robust pan-cancer gene-phosphosite associations were replicated in cell line samples. Of these, ARHGEF17, a predicted regulator of hippo-signaling, was further studied through (phospho)proteomics analysis where ARHGEF17 knockdown cells showed dys-regulation of hippo- and p38 signaling as well as immune related pathways. Using, RNAi, CRISPR and drug screening data we find evidence of kinase addiction in cancer cell lines identifying inhibitors for targeting of kinase-dependent cell lines. We propose copy number status of genes as useful predictors of differential impact of kinase inhibition, a strategy that may be of use in the future for anticancer therapies.

genomics↗